Hyung Soo Han

Title: Innovations of Hyung Soo Han

Introduction

Hyung Soo Han is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of three patents, his work focuses on peptides that have the potential to revolutionize diagnostics and treatment in this critical area of medicine.

Latest Patents

One of his latest patents is a peptide that passes through the blood-brain barrier and targets apoptosis in neurodegenerative brain disease sites. This invention relates to a peptide that specifically binds to apoptotic cells in affected areas, allowing for the detection and imaging of these cells. It also facilitates targeted drug delivery and theranosis for neurodegenerative diseases. Another significant patent involves stroke-targeting peptides, which comprise specific amino acid sequences. These peptides can bind to stroke cells, making them effective as diagnostic markers and in drug delivery compositions for stroke treatment.

Career Highlights

Hyung Soo Han has worked with the Kyungpook National University Industry-Academic Cooperation Foundation, where he has contributed to various research initiatives. He has also been associated with Hypoxi Co., Ltd., further enhancing his experience in the field of medical innovations.

Collaborations

Some of his notable coworkers include Byung-Heon Lee and Jong Won Lee, who have collaborated with him on various projects related to his patents and research.

Conclusion

Hyung Soo Han's innovative work in developing peptides for neurodegenerative diseases and stroke has the potential to significantly impact medical diagnostics and treatment. His contributions reflect a commitment to advancing healthcare through scientific research and innovation.